Auxo Firm Directory · Independent Research Profile

Ffl Partners

FFL Partners is a San Francisco-based private equity firm investing in middle-market businesses in healthcare and tech-enabled services. It generally commits $50-200 million per transaction, uses its SEED process, and provides high-engagement operating support.

Key takeaway

What stands out about Ffl Partners

FFL Partners publicly describes a North American middle-market strategy focused on healthcare and tech-enabled services. Its stated criteria include above-market performance, strong service reputations, scalable management, effective human-capital practices, technology-enablement potential, and opportunities to accelerate growth with FFL.[1][2][7][10]

What does Ffl Partners invest in?

FFL Partners is a San Francisco-based focused private equity firm investing in middle-market businesses and operating through FFL Partners, LLC. The firm provides private equity investment and high-engagement operating support, including strategic guidance, operating resources, and support for growth initiatives.[1][2]

FFL uses a proprietary Sector Exploration and Expertise Development, or SEED, process. FFL describes SEED as an intensive, multi-year sourcing and value-creation strategy focused on targeted subsectors.

FFL’s stated operating model includes strategic guidance, operating resources, and support for growth initiatives. Its approach also includes a general preference for board representation while remaining flexible across a wide range of investment structures.[2]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information
FFL generally commits $50-200 million to each transaction, with larger commitments in select circumstances. It seeks companies with above-market performance, strong reputations for high-quality service, talented and scalable management, effective human-capital practices, potential for technology enablement, and an opportunity to accelerate growth with FFL. FFL generally seeks board representation but states that it is flexible across a wide range of investment structures.[2]

What should a business owner evaluate before considering a transaction with Ffl Partners?

An owner evaluating FFL should clarify the ownership percentage and governance rights proposed for the specific transaction, including how the firm’s stated preference for board representation would apply. The owner should also ask how FFL would evaluate the opportunity under its SEED process and targeted-subsector focus.

Because FFL states that it is flexible across investment structures and its public activity includes a minority-investor situation, owners should request transaction-specific detail on structure, management roles, future capital needs, add-on acquisitions, integration, and succession. The Janus RX announcement’s non-disclosure of transaction terms also makes it appropriate to request the consideration structure and other economic terms for the proposed transaction directly.[2][5][7]

01

What ownership percentage and governance rights would FFL seek for this company, and how would its stated preference for board representation apply

FFL generally seeks board representation but states that it is flexible across a wide range of investment structures.[2]
02

How would FFL determine whether this opportunity fits within its SEED process and targeted subsectors

FFL describes its SEED process as a multi-year sourcing and value-creation strategy focused on targeted subsectors.[2]
03

Which operating resources and growth initiatives would FFL propose for this business

FFL describes high-engagement operating support that includes strategic guidance, operating resources, and support for growth initiatives.[2]

What companies does Ffl Partners target?

FFL seeks companies with above-market performance, strong reputations for high-quality service, talented and scalable management, effective human-capital practices, potential for technology enablement, and an opportunity to accelerate growth with FFL.[2]

FFL specializes in two sectors: healthcare and tech-enabled services.[1]

FFL invests in healthy, growing North American businesses in healthcare and tech-enabled services.[2]

FFL’s public transaction record includes the formation of Pioneer HOA to pursue growth opportunities with homeowners association property managers and the completed merger of portfolio companies Abacus Group and Medicus IT.

FFL also announced that Apex Infusion entered into a definitive agreement to partner with SkyKnight Capital, with FFL remaining a minority investor. These announcements illustrate that its public activity includes company formation, portfolio-company combination, and a minority-investor situation.[5][8]

FFL’s official portfolio identifies current investments including Abacus, ALKU, Apex Infusion, Johnson County Clin-Trials, Pebl, Perlman Clinic, Pioneer HOA, U.S. Orthopaedic Partners, Waylin Partners, and WellStreet Urgent Care.

The official terms page states that portfolio companies presented on the website are examples and do not purport to be a complete list.[3][10]

  • FFL completed its investment in Waylin Partners on September 10, 2026.
  • On July 24, 2026, FFL announced that Apex Infusion entered into a definitive agreement to partner with SkyKnight Capital, with FFL remaining a minority investor.
  • FFL formed Pioneer HOA on March 9, 2026 to pursue growth opportunities with homeowners association property managers.
  • FFL completed the sale of Anova to Aurora Capital Partners on January 22, 2026.
  • FFL completed its investment in Janus RX on October 23, 2025. The transaction announcement describes Janus as a behavioral pharmacy operating more than 40 locations across 19 states.
  • FFL completed the merger of portfolio companies Abacus Group and Medicus IT on July 15, 2025.
[4][5][6][7][8]

What is not clear from Ffl Partners's public investment criteria?

The official Janus RX transaction announcement states that the terms of that private transaction were not disclosed.

FFL’s official terms page states that the portfolio companies presented on its website are examples and do not purport to be a complete list.[7][10]

Questions to ask when evaluating Ffl Partners as a buyer or investment partner

What ownership percentage and governance rights would FFL seek for this company, and how would its stated preference for board representation apply?
FFL generally seeks board representation but states that it is flexible across a wide range of investment structures.[2]
How would FFL determine whether this opportunity fits within its SEED process and targeted subsectors?
FFL describes its SEED process as a multi-year sourcing and value-creation strategy focused on targeted subsectors.[2]
Which operating resources and growth initiatives would FFL propose for this business?
FFL describes high-engagement operating support that includes strategic guidance, operating resources, and support for growth initiatives.[2]
How would FFL approach add-on acquisitions, integration, management succession, and future capital needs for this company?
FFL’s public materials describe support for growth initiatives, and its public transaction record includes the merger of Abacus Group and Medicus IT and the formation of Pioneer HOA to pursue growth opportunities.[2][5][8]
What consideration structure and other economic terms would apply to the proposed transaction?
The official Janus RX transaction announcement states that the terms of that private transaction were not disclosed, so transaction-specific economics should be requested directly for the opportunity under consideration.[7]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Services / capabilities
  3. Transaction / portfolio evidence
  4. Transaction / portfolio evidence
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. SEC investment adviser record
  10. Structure / regulatory context
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.